InvestorsHub Logo
Followers 14
Posts 3822
Boards Moderated 1
Alias Born 07/07/2002

Re: None

Friday, 03/23/2012 11:05:16 AM

Friday, March 23, 2012 11:05:16 AM

Post# of 195
The shift of focus to vascular applications is what has me interested in Hansen. The proposition that Hansen can do electrophysiology procedures safely is iffy based upon FDA filings. The company has said that the vascular market is much bigger than the EP market so that seems to be the right strategy. What types of procedures will they do in vascular and how big are those markets? Are these related to structural heart diseases? Valves? Stents? etc. I would like appreciate a discussion if people have looked at that.